Quelles complications peuvent survenir avec le lymphome intraoculaire ?
Les complications incluent la perte de vision, le glaucome et des infections secondaires.
ComplicationsPerte de visionGlaucome
#2
Le lymphome intraoculaire peut-il entraîner des métastases ?
Oui, il peut se propager à d'autres parties du corps, bien que ce soit rare.
MétastasesPropagationRare
#3
Comment le traitement peut-il causer des complications ?
Les traitements comme la chimiothérapie peuvent affaiblir le système immunitaire, augmentant le risque d'infections.
ChimiothérapieSystème immunitaireInfections
#4
Le suivi régulier peut-il prévenir les complications ?
Oui, un suivi régulier permet de détecter et de traiter rapidement les complications.
Suivi régulierPréventionComplications
#5
Quelles sont les complications à long terme possibles ?
Les complications à long terme peuvent inclure des problèmes de vision persistants et des effets secondaires des traitements.
Complications à long termeProblèmes de visionEffets secondaires
Facteurs de risque
5
#1
Quels sont les principaux facteurs de risque du lymphome intraoculaire ?
Les principaux facteurs incluent l'immunodépression, l'âge avancé et certaines infections.
Facteurs de risqueImmunodépressionInfections
#2
Les antécédents familiaux augmentent-ils le risque ?
Oui, des antécédents familiaux de lymphome peuvent augmenter le risque de développer la maladie.
Antécédents familiauxRisqueLymphome
#3
Les personnes immunodéprimées sont-elles plus à risque ?
Oui, les personnes immunodéprimées, comme celles atteintes du VIH, ont un risque accru.
ImmunodépressionVIHRisque accru
#4
Certaines infections virales sont-elles des facteurs de risque ?
Oui, des infections comme le virus Epstein-Barr sont associées à un risque accru de lymphome.
Infections viralesVirus Epstein-BarrRisque accru
#5
L'exposition à des produits chimiques augmente-t-elle le risque ?
Certaines études suggèrent que l'exposition à des produits chimiques peut augmenter le risque de lymphome.
Produits chimiquesExpositionRisque
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Lymphome intraoculaire : Questions médicales les plus fréquentes",
"headline": "Lymphome intraoculaire : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Lymphome intraoculaire : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-30",
"dateModified": "2025-04-24",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Lymphome intraoculaire"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Lymphomes",
"url": "https://questionsmedicales.fr/mesh/D008223",
"about": {
"@type": "MedicalCondition",
"name": "Lymphomes",
"code": {
"@type": "MedicalCode",
"code": "D008223",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C20.683.515.761"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Lymphome intraoculaire",
"alternateName": "Intraocular Lymphoma",
"code": {
"@type": "MedicalCode",
"code": "D064090",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Gezhi Xu",
"url": "https://questionsmedicales.fr/author/Gezhi%20Xu",
"affiliation": {
"@type": "Organization",
"name": "Department of Ophthalmology, Fudan University Eye and ENT Hospital, Fudan University, Shanghai, China; Shanghai Key Laboratory of Visual Impairment and Restoration, Fudan University Eye and ENT Hospital, Fudan University, Shanghai, China; NHC Key Laboratory of Myopia (Fudan University); Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, China."
}
},
{
"@type": "Person",
"name": "Satoru Kase",
"url": "https://questionsmedicales.fr/author/Satoru%20Kase",
"affiliation": {
"@type": "Organization",
"name": "Department of Ophthalmology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan."
}
},
{
"@type": "Person",
"name": "Daiju Iwata",
"url": "https://questionsmedicales.fr/author/Daiju%20Iwata",
"affiliation": {
"@type": "Organization",
"name": "Department of Ophthalmology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan."
}
},
{
"@type": "Person",
"name": "Kayo Suzuki",
"url": "https://questionsmedicales.fr/author/Kayo%20Suzuki",
"affiliation": {
"@type": "Organization",
"name": "Department of Ophthalmology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan."
}
},
{
"@type": "Person",
"name": "Kenichi Namba",
"url": "https://questionsmedicales.fr/author/Kenichi%20Namba",
"affiliation": {
"@type": "Organization",
"name": "Department of Ophthalmology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Validity of the revised Diagnostic and Statistical Manual of Mental Disorders-5 cross-cutting symptom measure as implemented in community mental health settings.",
"datePublished": "2023-10-14",
"url": "https://questionsmedicales.fr/article/37844781",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jad.2023.10.077"
}
},
{
"@type": "ScholarlyArticle",
"name": "Interrater reliability of criterion A of the alternative model for personality disorder (Diagnostic and Statistical Manual for Mental Disorders, Fifth Edition-Section III): A meta-analysis.",
"datePublished": "2023-05-25",
"url": "https://questionsmedicales.fr/article/37227864",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1037/per0000631"
}
},
{
"@type": "ScholarlyArticle",
"name": "Item Response Theory Analyses of Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) Criteria Adapted to Screen Use Disorder: Exploratory Survey.",
"datePublished": "2022-07-27",
"url": "https://questionsmedicales.fr/article/35896018",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2196/31803"
}
},
{
"@type": "ScholarlyArticle",
"name": "Psychopathy and antisocial personality disorder in the fifth edition of the American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders: An attempted replication of Wygant et al. (2016).",
"datePublished": "2023-05-25",
"url": "https://questionsmedicales.fr/article/37227862",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1037/per0000626"
}
},
{
"@type": "ScholarlyArticle",
"name": "Functional impairment, insight, and comparison between criteria for gaming disorder in the International Classification of Diseases, 11 Edition and internet gaming disorder in Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition.",
"datePublished": "2022-11-02",
"url": "https://questionsmedicales.fr/article/36326855",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1556/2006.2022.00079"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies du système immunitaire",
"item": "https://questionsmedicales.fr/mesh/D007154"
},
{
"@type": "ListItem",
"position": 3,
"name": "Syndromes immunoprolifératifs",
"item": "https://questionsmedicales.fr/mesh/D007160"
},
{
"@type": "ListItem",
"position": 4,
"name": "Syndromes lymphoprolifératifs",
"item": "https://questionsmedicales.fr/mesh/D008232"
},
{
"@type": "ListItem",
"position": 5,
"name": "Lymphomes",
"item": "https://questionsmedicales.fr/mesh/D008223"
},
{
"@type": "ListItem",
"position": 6,
"name": "Lymphome intraoculaire",
"item": "https://questionsmedicales.fr/mesh/D064090"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Lymphome intraoculaire - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Lymphome intraoculaire",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-03",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Lymphome intraoculaire",
"description": "Comment diagnostique-t-on un lymphome intraoculaire ?\nQuels tests sont utilisés pour confirmer le lymphome intraoculaire ?\nQuels signes cliniques indiquent un lymphome intraoculaire ?\nLe lymphome intraoculaire peut-il être confondu avec d'autres maladies ?\nQuel rôle joue la biopsie dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D064090?mesh_terms=Diagnostic+and+Statistical+Manual+of+Mental+Disorders#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Lymphome intraoculaire",
"description": "Quels sont les symptômes courants du lymphome intraoculaire ?\nLe lymphome intraoculaire cause-t-il des changements de vision ?\nPeut-on avoir des symptômes sans douleur ?\nLes symptômes peuvent-ils varier d'un patient à l'autre ?\nY a-t-il des symptômes systémiques associés ?",
"url": "https://questionsmedicales.fr/mesh/D064090?mesh_terms=Diagnostic+and+Statistical+Manual+of+Mental+Disorders#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Lymphome intraoculaire",
"description": "Peut-on prévenir le lymphome intraoculaire ?\nQuels facteurs de risque sont associés au lymphome intraoculaire ?\nLes infections peuvent-elles être évitées pour réduire le risque ?\nLe dépistage précoce aide-t-il à la prévention ?\nY a-t-il des recommandations pour les personnes à risque ?",
"url": "https://questionsmedicales.fr/mesh/D064090?mesh_terms=Diagnostic+and+Statistical+Manual+of+Mental+Disorders#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Lymphome intraoculaire",
"description": "Quels traitements sont disponibles pour le lymphome intraoculaire ?\nLa chimiothérapie est-elle efficace pour ce type de lymphome ?\nLa radiothérapie est-elle utilisée dans le traitement ?\nQuand la chirurgie est-elle nécessaire ?\nY a-t-il des traitements expérimentaux disponibles ?",
"url": "https://questionsmedicales.fr/mesh/D064090?mesh_terms=Diagnostic+and+Statistical+Manual+of+Mental+Disorders#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Lymphome intraoculaire",
"description": "Quelles complications peuvent survenir avec le lymphome intraoculaire ?\nLe lymphome intraoculaire peut-il entraîner des métastases ?\nComment le traitement peut-il causer des complications ?\nLe suivi régulier peut-il prévenir les complications ?\nQuelles sont les complications à long terme possibles ?",
"url": "https://questionsmedicales.fr/mesh/D064090?mesh_terms=Diagnostic+and+Statistical+Manual+of+Mental+Disorders#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Lymphome intraoculaire",
"description": "Quels sont les principaux facteurs de risque du lymphome intraoculaire ?\nLes antécédents familiaux augmentent-ils le risque ?\nLes personnes immunodéprimées sont-elles plus à risque ?\nCertaines infections virales sont-elles des facteurs de risque ?\nL'exposition à des produits chimiques augmente-t-elle le risque ?",
"url": "https://questionsmedicales.fr/mesh/D064090?mesh_terms=Diagnostic+and+Statistical+Manual+of+Mental+Disorders#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on un lymphome intraoculaire ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par examen ophtalmologique, imageries et biopsies."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour confirmer le lymphome intraoculaire ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent l'échographie, l'IRM et l'analyse du liquide vitré."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent un lymphome intraoculaire ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme la vision floue, des douleurs oculaires et des lésions rétiniennes peuvent indiquer la maladie."
}
},
{
"@type": "Question",
"name": "Le lymphome intraoculaire peut-il être confondu avec d'autres maladies ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut être confondu avec des infections ou d'autres tumeurs oculaires."
}
},
{
"@type": "Question",
"name": "Quel rôle joue la biopsie dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "La biopsie permet d'analyser les cellules et de confirmer la présence de lymphome."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants du lymphome intraoculaire ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent vision floue, douleur, rougeur et décoloration de l'œil."
}
},
{
"@type": "Question",
"name": "Le lymphome intraoculaire cause-t-il des changements de vision ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut entraîner des changements de vision, y compris des taches ou des ombres."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des symptômes sans douleur ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains patients peuvent avoir des symptômes sans douleur oculaire significative."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils varier d'un patient à l'autre ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier en fonction de l'étendue et de la localisation du lymphome."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes systémiques associés ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes systémiques comme la fièvre et la perte de poids peuvent également survenir."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir le lymphome intraoculaire ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de méthode de prévention spécifique, mais un suivi régulier est conseillé."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque sont associés au lymphome intraoculaire ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'immunodépression, certaines infections virales et l'âge avancé."
}
},
{
"@type": "Question",
"name": "Les infections peuvent-elles être évitées pour réduire le risque ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, éviter les infections virales comme le VIH peut réduire le risque de lymphome."
}
},
{
"@type": "Question",
"name": "Le dépistage précoce aide-t-il à la prévention ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le dépistage précoce peut aider à identifier les problèmes oculaires avant qu'ils ne deviennent graves."
}
},
{
"@type": "Question",
"name": "Y a-t-il des recommandations pour les personnes à risque ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes à risque devraient consulter régulièrement un ophtalmologiste pour un suivi."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour le lymphome intraoculaire ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la chimiothérapie, la radiothérapie et parfois la chirurgie."
}
},
{
"@type": "Question",
"name": "La chimiothérapie est-elle efficace pour ce type de lymphome ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la chimiothérapie est souvent efficace, surtout pour les lymphomes non hodgkiniens."
}
},
{
"@type": "Question",
"name": "La radiothérapie est-elle utilisée dans le traitement ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la radiothérapie peut être utilisée pour cibler les cellules cancéreuses dans l'œil."
}
},
{
"@type": "Question",
"name": "Quand la chirurgie est-elle nécessaire ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "La chirurgie est envisagée si le lymphome provoque des complications ou ne répond pas aux autres traitements."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements expérimentaux disponibles ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des traitements expérimentaux comme les thérapies ciblées sont en cours d'évaluation."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec le lymphome intraoculaire ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la perte de vision, le glaucome et des infections secondaires."
}
},
{
"@type": "Question",
"name": "Le lymphome intraoculaire peut-il entraîner des métastases ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut se propager à d'autres parties du corps, bien que ce soit rare."
}
},
{
"@type": "Question",
"name": "Comment le traitement peut-il causer des complications ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements comme la chimiothérapie peuvent affaiblir le système immunitaire, augmentant le risque d'infections."
}
},
{
"@type": "Question",
"name": "Le suivi régulier peut-il prévenir les complications ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un suivi régulier permet de détecter et de traiter rapidement les complications."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications à long terme possibles ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications à long terme peuvent inclure des problèmes de vision persistants et des effets secondaires des traitements."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque du lymphome intraoculaire ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les principaux facteurs incluent l'immunodépression, l'âge avancé et certaines infections."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux augmentent-ils le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de lymphome peuvent augmenter le risque de développer la maladie."
}
},
{
"@type": "Question",
"name": "Les personnes immunodéprimées sont-elles plus à risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes immunodéprimées, comme celles atteintes du VIH, ont un risque accru."
}
},
{
"@type": "Question",
"name": "Certaines infections virales sont-elles des facteurs de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des infections comme le virus Epstein-Barr sont associées à un risque accru de lymphome."
}
},
{
"@type": "Question",
"name": "L'exposition à des produits chimiques augmente-t-elle le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines études suggèrent que l'exposition à des produits chimiques peut augmenter le risque de lymphome."
}
}
]
}
]
}
Department of Ophthalmology, Fudan University Eye and ENT Hospital, Fudan University, Shanghai, China; Shanghai Key Laboratory of Visual Impairment and Restoration, Fudan University Eye and ENT Hospital, Fudan University, Shanghai, China; NHC Key Laboratory of Myopia (Fudan University); Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, China.
Department of Ophthalmology, Fudan University Eye and ENT Hospital, Fudan University, Shanghai, China; Shanghai Key Laboratory of Visual Impairment and Restoration, Fudan University Eye and ENT Hospital, Fudan University, Shanghai, China; NHC Key Laboratory of Myopia (Fudan University); Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, China.
Department of Ophthalmology, Fudan University Eye and ENT Hospital, Fudan University, Shanghai, China; Shanghai Key Laboratory of Visual Impairment and Restoration, Fudan University Eye and ENT Hospital, Fudan University, Shanghai, China; NHC Key Laboratory of Myopia (Fudan University); Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, China.
Department of Ophthalmology, Fudan University Eye and ENT Hospital, Fudan University, Shanghai, China; Shanghai Key Laboratory of Visual Impairment and Restoration, Fudan University Eye and ENT Hospital, Fudan University, Shanghai, China; NHC Key Laboratory of Myopia (Fudan University); Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, China.
Department of Ophthalmology, Fudan University Eye and ENT Hospital, Fudan University, Shanghai, China; Shanghai Key Laboratory of Visual Impairment and Restoration, Fudan University Eye and ENT Hospital, Fudan University, Shanghai, China; NHC Key Laboratory of Myopia (Fudan University); Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, China.
Department of Ophthalmology, Fudan University Eye and ENT Hospital, Fudan University, Shanghai, China; Shanghai Key Laboratory of Visual Impairment and Restoration, Fudan University Eye and ENT Hospital, Fudan University, Shanghai, China; NHC Key Laboratory of Myopia (Fudan University); Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, China.
Department of Ophthalmology, Fudan University Eye and ENT Hospital, Fudan University, Shanghai, China; Shanghai Key Laboratory of Visual Impairment and Restoration, Fudan University Eye and ENT Hospital, Fudan University, Shanghai, China; NHC Key Laboratory of Myopia (Fudan University); Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, China. Electronic address: qngchang@aliyun.com.
Department of Ophthalmology and Visual Science, Catholic University Lymphoma Group, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
The purpose of this study was to validate the Diagnostic and Statistical Manual of Mental Disorders-5 (DSM-5) Cross-Cutting Symptom Measure (CCSM) as a screening tool for a wide variety of disorders w...
Participants (N = 851) were referred for coordinated specialty care services (mean age = 20.26 years (SD = 2.97); 82.5 % Caucasian, 7.5 % African American, 0.7 % Native American, 0.7 % Pacific Islande...
At optimal cut-score, specificity ranged from 57 to 77 % for depression, anxiety, substance use and psychosis domains; sensitivity ranged from 63 to 72 %. Scores for depression, anxiety, substance use...
Criterion measures did not have inter-rater reliabilities as this is generally prohibitive in clinic settings....
The CCSM could provide a first step in screening for multiple disorders; however, it cannot replace structured interviews for making diagnoses related to these conditions....
The alternative model for personality disorder (AMPD) is currently included in Section III of the Diagnostic and Statistical Manual for Mental Disorders, Fifth Edition (DSM-5). This review sought to s...
Screen use is part of daily life worldwide and morbidity related to excess use of screens has been reported. Some use of screens in excess could indicate a screen use disorder (ScUD). An integrative a...
Our goals were (1) to describe screen uses in a general population sample and (2) to test the unidimensionality, local independence, and psychometric properties of the 9 Diagnostic and Statistical Man...
This cross-sectional survey in a French suburban city targeted adults and adolescents. A self-administered questionnaire covered the main types of screens used and their use for various activities in ...
Among the 300 participants, 171 (57.0%) were female (mean age 27 years), 297 (99.0%) used screens, 134 (44.7%) reported at least one criterion (potential problem users), and 5 (1.7%) reported 5 or mor...
We described screen uses in a French community sample and have shown that the adaptation of the DSM-5 IGD to "ScUD" has good psychometric validity and is discriminating, confirming our hypothesis. We ...
This study evaluated the consistency between the International Classification of Diseases, 11th Edition (ICD-11) for gaming disorder (ICD-11-GD) and Diagnostic and Statistical Manual of Mental Disorde...
We recruited 60 participants with GD, 45 participants who engaged in hazardous gaming (HG), and 120 controls based on a diagnostic interview. Their operationalization of functional impairment and stag...
We observed satisfactory consistency (kappa value = 0.80) with a diagnostic accuracy of 91.5% between the ICD-11-GD and DSM-5-IGD criteria. Furthermore, 16 participants with IGD in DSM-5 were determin...
There is a good consistency between ICD-11-GD and DSM-5-IGD criteria. The ICD-11 criteria have a high threshold for diagnosing GD. HG criteria could compensate for this high threshold and identify ind...
The conceptual basis of psychopathology within cancer survivorship is critical, as the chosen conceptualisation informs assessment and explanatory models, as well as interventions and supportive care ...
Age-related psychometric differences in Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) opioid use disorder (OUD) diagnostic criteria have been hypothesized, but not been te...
People who participated in the 2012-2013 National Epidemiologic Survey on Alcohol and Related Conditions III and reported past 12-month nonmedical use of prescription opioids were included. YAs were 1...
One in 5 people met the DSM-5 OUD diagnostic criteria for OUD within the past 12 months, with the most endorsed criteria being tolerance (17.96%). DIF was identified for 3 criteria, including (1) taki...
These findings suggest that there may be age-related variations in the DSM-5 OUD diagnostic criteria's ability to detect latent OUD. Future research should identify contributing factors and the influe...
There is a scarcity of summarizing data on the epidemiology of insomnia in older persons, especially when diagnosed with international criteria. This study aimed to estimate the prevalence and correla...
Through PubMed/MEDLINE, EMBASE, and Web of Science (WoS), we searched for relevant articles published before June 28, 2023. The risk of bias was weighed using the Joanna Briggs Institute's (JBI's) cri...
We included 18,270 participants across 16 studies. The male/female ratio was 0.89 (12 studies), and the mean age varied from 65.9 to 83.1 years (8 studies). The pooled prevalence of insomnia was 19.6%...
Nearly one in every five old individuals was considered to have insomnia disorder, which was associated with the gender and the existence of mental health and/or somatic conditions....
We registered the protocol in the International Prospective Register of Systematic Reviews (PROSPERO) with registration number: CRD42022344675....
The alternative model of personality disorders (AMPD) traits were designed to maintain continuity with the Section II personality disorder (PD) diagnoses by retaining the same clinical information. Wh...
The Impact of Event Scale-Revised (IES-R) is a widely used self-report for assessing posttraumatic stress disorder (PTSD), originally aligned with Diagnostic and Statistical Manual of Mental Disorders...
A total of 238 participants recruited from multiple psychiatric centers, including 67 patients with PTSD, 72 patients with psychiatric controls, and 99 healthy controls, were included in the study. Al...
The IES-R demonstrated good internal consistency and a high correlation with the PCL-5. Through factor analysis, 5 distinct dimensions emerged within the IES-R: sleep disturbance, intrusion, hyperarou...
These findings underscore the scale's concurrent validity with the DSM-5 PTSD criteria and its effectiveness as a screening tool. Implementing a cutoff score of 25 on the IES-R can enhance its utility...